Search Results

There are 10243 results for: content related to: Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. You have free access to this content
    An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1433–1444, Marc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 26 SEP 2011, DOI: 10.1002/hep.24641

  3. You have free access to this content
    Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1477–1492, Vincent Leroy, Lawrence Serfaty, Marc Bourlière, Jean-Pierre Bronowicki, Patrick Delasalle, Alexandre Pariente, Stanislas Pol, Fabien Zoulim and Georges-Philippe Pageaux

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02856.x

  4. You have free access to this content
    Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C

    Hepatology

    Volume 56, Issue 3, September 2012, Pages: 850–860, Calogero Cammà, Salvatore Petta, Marco Enea, Raffaele Bruno, Fabrizio Bronte, Vincenza Capursi, Americo Cicchetti, Giorgio L. Colombo, Vito Di Marco, Antonio Gasbarrini, Antonio Craxì and on behalf of the WEF Study Group

    Version of Record online : 12 JUL 2012, DOI: 10.1002/hep.25734

  5. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 59–70, Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12272

  6. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  7. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Version of Record online : 30 SEP 2013, DOI: 10.1002/phar.1349

  8. The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

    Journal of Viral Hepatitis

    Volume 22, Issue 3, March 2015, Pages: 254–262, T. Oze, N. Hiramatsu, T. Yakushijin, R. Yamada, N. Harada, N. Morishita, M. Oshita, E. Mita, T. Ito, Y. Inui, M. Inada, S. Tamura, H. Yoshihara, Y. Imai, M. Kato, T. Miyagi, Y. Yoshida, T. Tatsumi, A. Kasahara, N. Hayashi and T. Takehara

    Version of Record online : 31 JUL 2014, DOI: 10.1111/jvh.12289

  9. Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment

    The Journal of Clinical Pharmacology

    Volume 55, Issue 10, October 2015, Pages: 1147–1156, Sivi Ouwerkerk-Mahadevan, Atef Halabi, Blanka Cieslarová, Indra Aerts, James Witek, Rodica Van Solingen-Ristea and Donghan Luo

    Version of Record online : 7 JUL 2015, DOI: 10.1002/jcph.545

  10. You have free access to this content
    Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?

    Hepatology

    Volume 56, Issue 1, July 2012, Pages: 373–381, Alexander J. Thompson and John G. McHutchison

    Version of Record online : 3 JUL 2012, DOI: 10.1002/hep.25792

  11. You have full text access to this OnlineOpen article
    Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 21, Issue 5, May 2014, Pages: 341–347, Y. Karino, I. Ozeki, S. Hige, M. Kimura, T. Arakawa, T. Nakajima, Y. Kuwata, T. Sato, T. Ohmura and J. Toyota

    Version of Record online : 25 AUG 2013, DOI: 10.1111/jvh.12162

  12. Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1165–1171, Kazuto Fukuda, Yasuharu Imai, Naoki Hiramatsu, Keiko Irishio, Takumi Igura, Yoshiyuki Sawai, Sachiyo Kogita, Yuki Makino, Rui Mizumoto, Yasushi Matsumoto, Masanori Nakahara, Sinichiro Zushi, Nobuyuki Kajiwara, Tsugiko Oze, Sumio Kawata, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12229

  13. You have free access to this content
    Development and validation of a “capture-fusion” model to study drug sensitivity of patient-derived hepatitis C

    Hepatology

    Volume 61, Issue 4, April 2015, Pages: 1192–1204, Morven E. Cunningham, Alia Javaid, Jenny Waters, Joseph Davidson-Wright, Joshua L.C. Wong, Meleri Jones and Graham R. Foster

    Version of Record online : 13 FEB 2015, DOI: 10.1002/hep.27570

  14. Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients

    Hepatology Research

    Volume 43, Issue 7, July 2013, Pages: 691–701, Fumitaka Suzuki, Yoshiyuki Suzuki, Hitomi Sezaki, Norio Akuta, Yuya Seko, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Rie Mineta, Sachiyo Watahiki, Mariko Kobayashi, Yoshiyuki Nakayasu, Hidetaka Tsuda, Keiji Aoki, Ichimaro Yamada and Hiromitsu Kumada

    Version of Record online : 29 NOV 2012, DOI: 10.1111/hepr.12009

  15. You have free access to this content
    The new standard of HCV therapy: Treatment in therapy-naive patients

    Clinical Liver Disease

    Volume 1, Issue 1, February 2012, Pages: 12–15, Saurabh Agrawal and Paul Y. Kwo

    Version of Record online : 6 MAR 2012, DOI: 10.1002/cld.7

  16. Postmarketing surveillance of telaprevir-based triple therapy for chronic hepatitis C in Japan

    Hepatology Research

    Volume 45, Issue 13, December 2015, Pages: 1267–1275, Muneshige Shiraishi, Itsuro Umebayashi, Hiroaki Matsuda, Keisuke Sawamura, Aiko Okada, Masako Karino and Yoshihide Nogami

    Version of Record online : 4 MAR 2015, DOI: 10.1111/hepr.12502

  17. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  18. You have free access to this content
    Viral Hepatitis

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S2, October 2013, Pages: 151–177,

    Version of Record online : 10 SEP 2013, DOI: 10.1111/jgh.12365_14

  19. You have free access to this content
    Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection

    HIV Medicine

    Volume 15, Issue 2, February 2014, Pages: 108–115, V Martel-Laferrière, S Brinkley, K Bichoupan, S Posner, A Stivala, P Perumalswami, TD Schiano, M Sulkowski, DT Dieterich and AD Branch

    Version of Record online : 11 SEP 2013, DOI: 10.1111/hiv.12086

  20. Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection

    Hepatology Research

    Volume 47, Issue 8, July 2017, Pages: 773–782, Naoki Morishita, Naoki Hiramatsu, Tsugiko Oze, Ayako Urabe, Yuki Tahata, Ryoko Yamada, Takayuki Yakushijin, Atsushi Hosui, Sadaharu Iio, Akira Yamada, Hideki Hagiwara, Eiji Mita, Yukinori Yamada, Toshifumi Ito, Masami Inada, Kazuhiro Katayama, Iwao Yabuuchi, Yasuharu Imai, Hayato Hikita, Ryotaro Sakamori, Yuichi Yoshida, Tomohide Tatsumi, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 26 OCT 2016, DOI: 10.1111/hepr.12817